This patent covers methods of dedifferentiating cells, and redifferentiating them in order to produce islet-like cells for the treatment of diabetes.
This invention teaches how to generate neurons from skin. Essentially, the inventors found that through the process of isolating epidermal stem cells (basal cells), transfected said basal cells with genes encoding neurogenic transcription factors, suppressing transcription factors that maintain a differentiated phenotype (by for example antisense), and then culturing the cells with exogenous...
This invention is similar to patent 7041507, which was filed by the same inventors. The current invention teaches generation of neuronal-like cells through the transdifferentiation of epidermal basal cells. The invention has 3 independent claims covering, "An in vitro method of transdifferentiating an epidermal basal cell ", "A kit for transdifferentiating, in vitro, an epidermal...
This patent teaches how to induce "trandifferentiation" of epidermal cells into neurons. The neurons are useful for treatment of neurodegenerative diseases.
Gene therapy is limited by ability to transfect quiescent cells. Since the very primitive hematopoietic stem cells reside in a quiescent state, it is difficult to transfect them. This patent demonstrates transfection of early hematopoietic stem cells using an adeno-associated vector. The patent has one independent claim that covers:
A method for stably transferring
This patent provides frequencies of light that effect extracellular and cellular components. This patent is useful for regulation of stem cells after implantation into a host through non-pharmacological means.
Mesenchymal stem cells can be used as "universal donors" since they do not elicit rejection in certain situations. This patent teaches methods of differentiating mesenchymal stem cells into cartilage through growth on alginate layers.
This patent teaches how to generate cells of the lymphoid lineage in vitro through a variety of devices and culture techniques. This patent could be used for generating T suppressor cells in order to antigen-specifically inhibit autoimmunity.
This patent covers ways of inducing the generation of hematopoietic stem cells from embryonic stem cells. This is very useful since it may be possible to generate allogeneic hematopoietic stem cells for the whole population using such a method.
Dendritic cells are one of the most important cells of the immune system, having the unique ability to stimulate naive T cells. Additionally, under specific conditions, dendritic cells can give rise to T regulatory cells and dampen immune responses. The current patent teaches ways of generating dendritic cells from embryonic stem cells by culturing embryoid bodies with IL-3 and/or...